ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,887.20
      -1.02%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.52
      0.34%
      Bitcoin
      64,129.17
      -0.24%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aquestive Therapeutics Inc (AQST)

      7. Aquestive Therapeutics Inc (AQST) News

      AQST Aquestive Therapeutics Inc

      4.00
      0.10 (2.56%)
      Pre Market
      Last Updated: 04:05:57
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Aquestive Therapeutics Inc AQST NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.10 2.56% 4.00 04:05:57
      Open Price Low Price High Price Close Price Prev Close
      3.90
      more quote information »

      Recent News

      Date Time Source Heading
      4/12/202416:01GLOBEAquestive Therapeutics to Present Crossover Study Data for..
      4/01/202408:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
      3/25/202408:00GLOBEAquestive Therapeutics Announces Closing of Underwritten..
      3/19/202421:49GLOBEAquestive Therapeutics Announces Pricing of $75 Million..
      3/19/202416:01GLOBEAquestive Therapeutics Announces Proposed Public Offering of..
      3/14/202417:23GLOBEAquestive Therapeutics Announces Pivotal Study for Anaphylm™..
      3/11/202410:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202410:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202416:14EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202417:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      3/05/202417:09EDGAR2Form 8-K - Current report
      3/05/202417:05GLOBEAquestive Therapeutics Reports Full Year 2023 Financial..
      2/21/202408:00GLOBEAquestive Therapeutics to Report Fourth Quarter 2023..
      2/15/202408:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
      2/14/202415:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/12/202417:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
      1/30/202408:00GLOBEAquestive Therapeutics to Participate in Oppenheimer 34th..
      12/08/202310:46EDGAR2Form 8-K - Current report
      12/05/202308:51EDGAR2Form 8-K - Current report
      12/05/202308:00GLOBEAquestive Therapeutics Doses First Patient in Phase 3..
      11/10/202308:00GLOBEAquestive Therapeutics to Present Positive Data from..
      11/08/202317:04EDGAR2Form 8-K - Current report
      11/06/202317:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/06/202317:20EDGAR2Form 8-K - Current report
      11/06/202316:37GLOBEAquestive Therapeutics Reports Third Quarter 2023 Financial..
      11/02/202308:45EDGAR2Form 8-K - Current report
      11/02/202308:00GLOBEAquestive Therapeutics Completes $45 Million Debt..
      10/31/202308:00GLOBEAquestive Therapeutics to Report Third Quarter 2023..
      10/10/202312:04EDGAR2Form 8-K - Current report
      10/09/202308:00GLOBEAquestive Therapeutics Provides Business Update
      10/02/202316:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      10/02/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      9/20/202316:39EDGAR2Form 8-K - Current report
      9/20/202310:57DJNAquestive Therapeutics Shares Rise 12% on Anaphylm Trial..
      9/20/202309:04GLOBEAquestive Therapeutics Reaffirms Timeline and Pathway for..
      9/11/202308:00GLOBEAquestive Therapeutics Receives FDA Acceptance of New Drug..
      8/23/202308:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
      8/11/202313:14EDGAR2Form 8-K - Current report
      8/09/202317:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/09/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      AQST
      Aquestive Therapeutics
      Delayed Upgrade Clock